Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Trial of ABSK043, an Oral PD-L1 Inhibitor, in Patients With Angiogenic Sarcomas
Apply
ABSK043
A Trial of ABSK043, an Oral PD-L1 Inhibitor, in Patients With Angiogenic Sarcomas
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step